LIANY — LianBio
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1831283 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2022 | 0 | 0 | -24,549,000 | -21,897,000 | 319,960,000 | 79,221,000 | 26,313,000 |
| Dec 2021 | 0 | 0 | -13,544,000 | -13,112,000 | 426,343,000 | 228,182,000 | 39,007,000 |
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2022 | 0 | -125,353,000 | -110,290,000 | 319,960,000 | 26,313,000 | — | -99,185,000 |
| Dec 2021 | 0 | -195,570,000 | -196,300,000 | 426,343,000 | 39,007,000 | — | -163,953,000 |
TTM Snapshot
Revenues TTM
$0
NetIncome TTM
$-35,009,000
OpCashFlow TTM
$0
Assets (Latest)
$319,960,000
Forward EPS
$-0.36
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.01T | $1133.00 | — |
| JNJ | JOHNSON & JOHNSON | $579.83B | $240.87 | — |
| ABBV | AbbVie Inc. | $402.35B | $227.73 | — |
| MRK | Merck & Co., Inc. | $294.03B | $119.05 | — |
| NVS | NOVARTIS AG | $292.07B | $153.07 | — |
Recent Insider Activity
No insider activity indexed for this ticker.